Journal
PPAR RESEARCH
Volume 2019, Issue -, Pages -Publisher
HINDAWI LTD
DOI: 10.1155/2019/7242030
Keywords
-
Categories
Funding
- China Foundation for Hepatitis Prevention and Control WBN Liver Disease Research Fund [CFHPC2019031]
- Innovation Plan of Health System of Science and Technology Commission of Putuo District, Shanghai [ptkwws201901]
Ask authors/readers for more resources
15-Deoxy-Delta-(12,14)-prostaglandin J2 (15d-PGJ2), a natural peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist, has been explored in some detail over the last 20 years. By triggering the PPAR-gamma signalling pathway, it plays many roles and exerts antitumour, anti-inflammatory, antioxidation, antifibrosis, and antiangiogenesis effects. Although many synthetic PPAR-gamma receptor agonists have been developed, as an endogenous product of PPAR-gamma receptors, 15d-PGJ2 has beneficial characteristics including rapid expression and the ability to contribute to a natural defence mechanism. In this review, we discuss the latest advances in our knowledge of the biological role of 15d-PGJ2 mediated through PPAR-gamma. It is important to understand its structure, synthesis, and functional mechanisms to develop preventive agents and limit the progression of associated diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available